您的位置: 首页 > 农业专利 > 详情页

DIVERSION-RESISTANT OPIOID FORMULATIONS
专利权人:
Elysium Therapeutics; Inc.
发明人:
Thomas E. JENKINS
申请号:
US16393812
公开号:
US20200113893A1
申请日:
2019.04.24
申请国别(地区):
US
年份:
2020
代理人:
摘要:
The present invention provides a composition comprising an opioid agonist, and a polymer-antagonist conjugate. The polymer-antagonist conjugate preferably does not hydrolyze upon administration to a patient, and does not bind to the opioid receptors. The covalent bond between the polymer and the antagonist in the conjugate is broken over a defined period of time to release the antagonist into the formulation. The released antagonist attenuates the liking of the agonist, thereby eliminating the incentive to the diversion of the medicines.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充